INTERNATIONAL PATENT: JANSSEN PHARMACEUTICA NV FILES APPLICATION FOR "COMBINATION THERAPY USING MALT1 AND BCL-2 INHIBITORS AND METHODS OF REDUCING REGULATORY T CELLS"

GENEVA, Dec. 29 -- JANSSEN PHARMACEUTICA NV (Turnhoutseweg 302340 Beerse) filed a patent application (PCT/EP2025/067046) for "COMBINATION THERAPY USING MALT1 AND BCL-2 INHIBITORS AND METHODS OF REDUCING REGULATORY T CELLS" on Jun 18, 2025. With publication no. WO/2025/262113, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FONTAN GABAS, Lorena (Janssen Pharmaceutica NVTurnhoutseweg 302340 Beerse), YIN, Jian (Janssen Research & Development, LLC920 US Route 202PO Box 300Raritan, New Jersey 08869), PEROVA, Tatiana (Janssen R...